SAN FRANCISCO, CA / ACCESSWIRE / July 31, 2022 / NextEvo Naturals, the science-driven wellness brand, recently introduced a new vessel to join its existing roster of absorption-forward, premium health products. The NextEvo CBD Stress Complex features a dynamic blend of pure CBD extract and Ashwagandha to target bodily tension and overall stress. By uniting pure CBD with the complex benefits of Ashwagandha, NextEvo Naturals is able to provide results-driven solutions to familiar wellness struggles in a way that’s accessible and reliable.
Built off the knowledge gained from working with Johnson & Johnson, John McDonagh, CEO and president of NextEvo Naturals, discovered a need for effective wellness support that actually did what was advertised. McDonagh and his team of executives amass decades of experience in the pharmaceutical and consumer goods industries, leading them to procure an elevated standard at the start of COVID-19. NextEvo Naturals specializes in using CBD to its maximum potential, which is predominantly concerned with proper absorption. In order to combat the complacency and apathy directed at CBD markets, NextEvo Naturals employed the use of SmartSorb™ Technology in its products to increase effectiveness and build trust with its consumers. Many CBD products on the market are deceptively oil-based, and thus do not absorb easily with our water-based bodies.
Similarly, the company utilizes this approach with their Stress Complex gummies, enhancing the properties of both pure CBD and Ashwagandha. This recognized adaptogen has been historically used to relieve stress and is a core ingredient in Eastern herbal medicine. The roots and leaves of this evergreen shrub have been most commonly enjoyed as a tea, and when coupled with NextEvo Naturals’ pure CBD extract, it creates a powerful solution to stress and anxiety.
The Stress Complex is offered in 30-gummy bottles, each gummy containing 15g of CBD per serving. This combination is a balanced example of how CBD and Ashwagandha work wonders when taken together. Separately, they can achieve similar results, but recent studies have shown that while Ashwagandha is effective on its own at both small and larger doses, CBD requires a bit more moderation. Preclinical studies with animals have shown that low to medium doses of CBD produce anxiety-reducing effects, while high doses actually increase anxiety. Too much CBD is counterproductive, but when paired with the likes of Ashwagandha, a balance is struck to achieve higher levels of reduced stress and anxiety.
NextEvo Naturals excel in gummies, capsules, and topical creams that invite a heightened concentration of self-care, overstepping conventional models by focusing on results rather than revenue. NextEvo’s gummies are significantly lower in sugar than their counterparts, and its pure CBD is clinically shown to have 4x greater absorption and enter the body in as little as 10 minutes. Coupled with Ashwagandha, products like the Stress Complex make big waves in a relatively tepid market.
The use of Ashwagandha for wellness purposes can be traced back to 6000 BC. Now, Ashwagandha is one of the natural product industry’s top 25 best selling ingredients, with estimated 2021 ashwagandha sales of $251 million, a 26.7% increase over the prior year, and with estimates that the market will reach $319 million by 2024.
The team behind NextEvo Naturals upholds themselves to a higher standard in product development, ensuring that every item made available receives a premium treatment that’s extensively backed by research and scientific evidence. The Stress Complex gummies are entering the market at just the right time when many consumers are seeking to expand their knowledge base on herbal adaptogens. The unity between pure CBD and Ashwagandha is a solution to consider when battling stress or anxiety in our day-to-day routines. As the name suggests, we’ve come upon a renaissance in health and wellness, the next evolution of which is sure to be as dynamic and sweeping as a proprietary blend of CBD and Ashwagandha.
SOURCE: NextEvo Naturals
View source version on accesswire.com:
Source: Financial Content